Simple blood test could help doctors tailor liver cancer treatment
NCT ID NCT07414433
Summary
This study aims to find out if specific substances in the blood can predict how well patients with liver cancer will respond to a standard treatment called chemoembolization (TACE). Researchers will follow 60 patients receiving this standard care, taking blood samples before and after treatment. They will compare the blood test results with standard CT or MRI scans to see if the blood tests can reliably indicate treatment success earlier.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KBC Bežanijska kosa
Belgrade, Serbia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.